Distinguished in Collapsed Lung

Dr. Nishant Gupta

Intensive Care Medicine
Office
200 Eden Ave, 
Cincinnati, OH 
Clinical Trials:Currently Recruiting for 1 Trial
Distinguished in Collapsed Lung
Office
200 Eden Ave, 
Cincinnati, OH 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Nishant Gupta is an Intensive Care Medicine provider in Cincinnati, Ohio. Dr. Gupta is rated as a Distinguished provider by MediFind in the treatment of Collapsed Lung. His top areas of expertise are Lymphangioleiomyomatosis, Acute Interstitial Pneumonia, Interstitial Lung Disease, Gastrostomy, and Lung Transplant.

His clinical research consists of co-authoring 174 peer reviewed articles and participating in 9 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 6 articles in the study of Collapsed Lung.

Specialties
Intensive Care Medicine
Licenses
Internal Medicine in OH
Hospital Affiliations
Cincinnati Children's Hospital Medical Center
West Chester Hospital
University Of Cincinnati Medical Center, LLC
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Buckeye Health Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
First Health
  • INSURANCE PLAN
  • MEDICARE PDP
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medical Health
  • HMO
  • PPO
Medical Mutual
  • HMO
  • PPO
Ohio Health Group
  • PPO
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 13 Less Insurance Carriers -

Locations

Office
200 Eden Ave, Cincinnati, OH 45219
Call: 513-475-8523
Other Locations
South Building-Multi-Specialty
7675 Wellness Way Ste 211, West Chester, OH 45069
Call: 513-475-8523

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

Idiopathic Pulmonary Fibrosis Prospective Outcomes (IPF-PRO) and Interstitial Lung Disease Prospective Outcomes (IPF-PRO/ILD-PRO) Registry
Idiopathic Pulmonary Fibrosis Prospective Outcomes (IPF-PRO) and Interstitial Lung Disease Prospective Outcomes (IPF-PRO/ILD-PRO) Registry
Enrollment Status: Recruiting
Publish Date: October 14, 2025
Optimizing and Standardizing 129Xe Gas Exchange MRI to Visualize Regional Therapy Response in Interstitial Lung Disease
Optimizing and Standardizing 129Xe Gas Exchange MRI to Visualize Regional Therapy Response in Interstitial Lung Disease
Enrollment Status: Completed
Publish Date: November 21, 2025
Intervention Type: Drug
Study Phase: Phase 2
A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis (TETON-1)
A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis (TETON-1)
Enrollment Status: Active_not_recruiting
Publish Date: September 08, 2025
Intervention Type: Device, Drug
Study Drug: Treprostinil
Study Phase: Phase 3
Phase 1b Double-Blind, Placebo-Controlled, Ascending Dose Trial: ORIN1001 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
Phase 1b Double-Blind, Placebo-Controlled, Ascending Dose Trial: ORIN1001 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
Enrollment Status: Suspended
Publish Date: May 30, 2025
Intervention Type: Drug
Study Drug: ORIN1001
Study Phase: Phase 1
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumab in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumab in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
Enrollment Status: Terminated
Publish Date: September 19, 2024
Intervention Type: Drug
Study Drug: Pamrevlumab
Study Phase: Phase 3
Sirolimus Treatment in Hospitalized Patients With COVID-19 Pneumonia (The SCOPE Trial)
Sirolimus Treatment in Hospitalized Patients With COVID-19 Pneumonia (The SCOPE Trial)
Enrollment Status: Completed
Publish Date: April 05, 2024
Intervention Type: Drug
Study Drug: Sirolimus
Study Phase: Phase 2
Assessment of Safety of Air Travel in Patients With Birt-Hogg-Dube Syndrome
Assessment of Safety of Air Travel in Patients With Birt-Hogg-Dube Syndrome
Enrollment Status: Completed
Publish Date: January 31, 2024
Intervention Type: Other
A Randomized, Double-Blind, Placebo-Controlled Dose Escalation and Verification Clinical Study to Assess the Safety and Efficacy of Pulsed Inhaled Nitric Oxide (iNO) in Subjects at Risk of Pulmonary Hypertension Associated With Pulmonary Fibrosis on Long Term Oxygen Therapy (Part 1 and Part 2) - REBUILD
A Randomized, Double-Blind, Placebo-Controlled Dose Escalation and Verification Clinical Study to Assess the Safety and Efficacy of Pulsed Inhaled Nitric Oxide (iNO) in Subjects at Risk of Pulmonary Hypertension Associated With Pulmonary Fibrosis on Long Term Oxygen Therapy (Part 1 and Part 2) - REBUILD
Enrollment Status: Terminated
Publish Date: July 27, 2023
Intervention Type: Combination product
Study Drug: INOpulse
Study Phase: Phase 3
Resveratrol and Sirolimus in Lymphangioleiomyomatosis Trial (RESULT)
Resveratrol and Sirolimus in Lymphangioleiomyomatosis Trial (RESULT)
Enrollment Status: Completed
Publish Date: February 01, 2023
Intervention Type: Drug
Study Drugs: Sirolimus, Resveratrol
Study Phase: Phase 2
View 8 Less Clinical Trials

174 Total Publications

Current Perspectives on The Diagnosis and Management of Lymphangioleiomyomatosis.
Current Perspectives on The Diagnosis and Management of Lymphangioleiomyomatosis.
Journal: Clinics in chest medicine
Published: October 19, 2025
View All 174 Publications
Similar Doctors
Advanced in Collapsed Lung
Dr. Christopher Orabella
Intensive Care Medicine
Advanced in Collapsed Lung
Dr. Christopher Orabella
Intensive Care Medicine

The Christ Hospital Physicians-Pulmonary Medicine

2123 Auburn Ave Ste 401, 
Cincinnati, OH 
 (1.1 miles away)
513-241-5489
Languages Spoken:
English
See accepted insurances

Christopher Orabella is an Intensive Care Medicine provider in Cincinnati, Ohio. Dr. Orabella is rated as a Distinguished provider by MediFind in the treatment of Collapsed Lung. His top areas of expertise are Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), Bronchiectasis, Pneumonia, and Gastrostomy.

Advanced in Collapsed Lung
Dr. Kiranmayee Lanka
Intensive Care Medicine
Advanced in Collapsed Lung
Dr. Kiranmayee Lanka
Intensive Care Medicine

The Christ Hospital Physicians-Pulmonary Medicine

2123 Auburn Ave Ste 401, 
Cincinnati, OH 
 (1.1 miles away)
513-241-5489
Languages Spoken:
English
See accepted insurances

Kiranmayee Lanka is an Intensive Care Medicine provider in Cincinnati, Ohio. Dr. Lanka is rated as a Distinguished provider by MediFind in the treatment of Collapsed Lung. Her top areas of expertise are Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), Acute Interstitial Pneumonia, Gastrostomy, and Endoscopy.

Advanced in Collapsed Lung
Dr. Mark Scott
Intensive Care Medicine
Advanced in Collapsed Lung
Dr. Mark Scott
Intensive Care Medicine

Tri-State Pulmonary Associates Inc.

2123 Auburn Ave Ste 401, 
Cincinnati, OH 
 (1.1 miles away)
513-241-5489
Languages Spoken:
English
See accepted insurances

Mark Scott is an Intensive Care Medicine provider in Cincinnati, Ohio. Dr. Scott is rated as an Advanced provider by MediFind in the treatment of Collapsed Lung. His top areas of expertise are Emphysema, Bullae, Pneumonia, Gastrostomy, and Endoscopy.

VIEW MORE COLLAPSED LUNG DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Gupta's expertise for a condition
ConditionClose
  • Elite
  • Acute Interstitial Pneumonia
    Dr. Gupta is
    Elite
    . Learn about Acute Interstitial Pneumonia.
    See more Acute Interstitial Pneumonia experts
  • Interstitial Lung Disease
    Dr. Gupta is
    Elite
    . Learn about Interstitial Lung Disease.
    See more Interstitial Lung Disease experts
  • Lymphangioleiomyomatosis
    Dr. Gupta is
    Elite
    . Learn about Lymphangioleiomyomatosis.
    See more Lymphangioleiomyomatosis experts
  • Distinguished
  • Birt-Hogg-Dube Syndrome
    Dr. Gupta is
    Distinguished
    . Learn about Birt-Hogg-Dube Syndrome.
    See more Birt-Hogg-Dube Syndrome experts
  • Collapsed Lung
    Dr. Gupta is
    Distinguished
    . Learn about Collapsed Lung.
    See more Collapsed Lung experts
  • Hypersensitivity Pneumonitis
    Dr. Gupta is
    Distinguished
    . Learn about Hypersensitivity Pneumonitis.
    See more Hypersensitivity Pneumonitis experts
  • Idiopathic Pulmonary Fibrosis
    Dr. Gupta is
    Distinguished
    . Learn about Idiopathic Pulmonary Fibrosis.
    See more Idiopathic Pulmonary Fibrosis experts
  • Pneumonia
    Dr. Gupta is
    Distinguished
    . Learn about Pneumonia.
    See more Pneumonia experts
  • Pulmonary Fibrosis
    Dr. Gupta is
    Distinguished
    . Learn about Pulmonary Fibrosis.
    See more Pulmonary Fibrosis experts
View All 7 Distinguished Conditions
  • Advanced
  • Lung Metastases
    Dr. Gupta is
    Advanced
    . Learn about Lung Metastases.
    See more Lung Metastases experts
  • Neurosarcoidosis
    Dr. Gupta is
    Advanced
    . Learn about Neurosarcoidosis.
    See more Neurosarcoidosis experts
  • Pulmonary Actinomycosis
    Dr. Gupta is
    Advanced
    . Learn about Pulmonary Actinomycosis.
    See more Pulmonary Actinomycosis experts
  • Systemic Sclerosis (SSc)
    Dr. Gupta is
    Advanced
    . Learn about Systemic Sclerosis (SSc).
    See more Systemic Sclerosis (SSc) experts
  • Experienced
  • Actinomycosis
    Dr. Gupta is
    Experienced
    . Learn about Actinomycosis.
    See more Actinomycosis experts
  • Branchiootorenal Syndrome
    Dr. Gupta is
    Experienced
    . Learn about Branchiootorenal Syndrome.
    See more Branchiootorenal Syndrome experts
  • Bronchiectasis
    Dr. Gupta is
    Experienced
    . Learn about Bronchiectasis.
    See more Bronchiectasis experts
  • Bronchiolitis Obliterans
    Dr. Gupta is
    Experienced
    . Learn about Bronchiolitis Obliterans.
    See more Bronchiolitis Obliterans experts
  • Bronchogenic Cyst
    Dr. Gupta is
    Experienced
    . Learn about Bronchogenic Cyst.
    See more Bronchogenic Cyst experts
  • Cerebral Hypoxia
    Dr. Gupta is
    Experienced
    . Learn about Cerebral Hypoxia.
    See more Cerebral Hypoxia experts
View All 31 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment

    If you are experiencing a medical emergency, call 9-1-1.

    MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

    Patient Details

    This information is for the patient who will be seen at the appointment.

      Close

      Returning patient? Use your address on file with the provider.

      Insurance Details

      Please provide information of the primary insurance holder as the practice may require this information to schedule.

      Insurance Provider *
      Insurance ProviderClose

      Appointments Details

      Let’s get more information about your appointment.

              0 / 1000
              0 / 1000
              By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.